Free shipping on orders over $150  |  All products third-party tested for 99%+ purity Shop Now

Is TB-500 FDA Approved?

Learn whether TB-500 is FDA approved. Understand the regulatory status of TB-500, how compounding pharmacies fit in, and what this means for patients.

Reviewed by Form Blends Medical Team|Updated March 2026

Is TB-500 FDA Approved?

No, TB-500 is not FDA approved as a finished pharmaceutical drug. It is available in the United States through licensed compounding pharmacies when prescribed by a physician for individual patient use. This is a common regulatory pathway for many peptide therapies, and it does not mean the compound is illegal or unsafe. At FormBlends, we work exclusively with licensed compounding pharmacies that follow strict quality and safety standards, and every TB-500 prescription is written by a licensed physician after a thorough medical evaluation.

Understanding the difference between FDA approval and compounding pharmacy availability is important for anyone considering peptide therapy. Here is what you need to know.

What Does FDA Approval Actually Mean?

When a drug receives FDA approval, it means the manufacturer has submitted extensive clinical trial data demonstrating that the drug is safe and effective for a specific medical condition. This process typically takes years and costs hundreds of millions of dollars . The FDA then reviews the data, and if satisfied, grants approval for the drug to be marketed and sold for that specific indication.

Most peptides used in wellness and regenerative medicine, including TB-500, BPC-157, and many growth hormone-releasing peptides, have not gone through this process. The primary reason is economic: the FDA approval pathway is designed for patentable pharmaceutical products that will generate enough revenue to justify the investment. Naturally occurring peptides and their synthetic analogs are difficult to patent, which means pharmaceutical companies have limited financial incentive to fund the required clinical trials .

The absence of FDA approval does not mean these compounds are unstudied. TB-500 (thymosin beta-4) has been the subject of significant preclinical and early clinical research. It simply has not completed the full regulatory journey required for FDA-approved status.

How Is TB-500 Legally Available Without FDA Approval?

TB-500 is available through a process called pharmaceutical compounding. Compounding pharmacies are licensed facilities that prepare customized medications for individual patients based on a physician's prescription. This practice is regulated under federal law (specifically Section 503A of the Federal Food, Drug, and Cosmetic Act) and by state pharmacy boards .

Compounding has a long history in American medicine. It allows physicians to prescribe medications that are not commercially available, in custom dosages, or in forms better suited to a patient's needs. Many commonly used medications, from hormone replacement therapy to certain dermatological treatments, are prepared by compounding pharmacies.

For TB-500 to be legally compounded and dispensed, the following conditions must be met:

  • A licensed physician must evaluate the patient and determine that TB-500 is medically appropriate
  • The physician must write a valid prescription
  • A licensed compounding pharmacy must prepare the medication following current good manufacturing practices
  • The compound must be dispensed to the individual patient named on the prescription

This is exactly how our process works at FormBlends. Every patient receives a physician evaluation before any peptide is prescribed.

Yes, TB-500 is legal to prescribe and use in the United States when obtained through the proper channels described above. It is not a controlled substance. However, it is important to distinguish between legally prescribed TB-500 from a compounding pharmacy and TB-500 purchased from unregulated online sources.

Products sold by research chemical suppliers or overseas vendors are labeled "for research purposes only" and are not intended for human use. These products are not subject to the same quality controls as those from licensed US compounding pharmacies. They may contain impurities, incorrect concentrations, or even entirely different substances . Using these products carries real risk, and we strongly advise against it.

What About TB-500 and Sports Drug Testing?

TB-500 is listed as a prohibited substance by the World Anti-Doping Agency (WADA) under the category of peptide hormones and growth factors . This means that competitive athletes subject to drug testing should not use TB-500 without understanding the consequences. A positive test could result in suspension or other penalties.

If you are a competitive athlete in a tested sport, discuss this with your physician before starting any peptide therapy. Our team at FormBlends can help you understand which therapies are compatible with your competitive obligations.

Has There Been Any Progress Toward FDA Approval for TB-500?

The parent compound, thymosin beta-4, has been studied in several clinical contexts. RegeneRx Biopharmaceuticals conducted clinical trials investigating thymosin beta-4 for corneal wound healing (under the name RGN-259) and for pressure ulcers and venous stasis ulcers . These trials showed promising results in some endpoints, but the compound has not yet received FDA approval for any indication.

The path forward for thymosin beta-4 or TB-500 as an FDA-approved drug remains uncertain. If future trials are funded and produce strong enough data, approval is possible, but there is no timeline for this outcome.

How Does FormBlends Ensure Quality Without FDA Approval?

The lack of FDA approval for TB-500 means that quality assurance falls primarily on the compounding pharmacy and the prescribing physician. At FormBlends, we address this by partnering only with compounding pharmacies that:

  • Hold active state pharmacy licenses
  • Follow current good manufacturing practices (cGMP) or equivalent standards
  • Conduct third-party testing for purity and potency
  • Provide certificates of analysis for their compounds

Our physicians also stay current with the latest research on TB-500 safety and efficacy, so the protocols we prescribe reflect the best available evidence.

What Should You Ask Your Provider About TB-500?

If you are considering TB-500 therapy with any provider, here are questions worth asking:

  1. Where is the TB-500 compounded, and is the pharmacy licensed?
  2. Is third-party purity testing conducted on the product?
  3. Will a licensed physician review my health history before prescribing?
  4. What ongoing medical support is available during my treatment?

At FormBlends, we are happy to answer all of these questions and more. Transparency about sourcing, quality, and medical oversight is a core part of how we operate. While TB-500 may not carry an FDA stamp of approval, we take every step available to ensure our patients receive a safe, high-quality product under proper medical supervision.

Related Articles